Related Experiment Video
Updated: Jun 9, 2026
08:39
Experimental Protocol for Detecting Mitochondrial Function in Hepatocytes Exposed to Organochlorine Pesticides
Published on: September 16, 2020
Targeting Mitochondria in Aging-Related Diseases: Therapeutic Potential and Obstacles
Zijie Xiang1, Yu Chen1, Xishui Liu2
1Department of Orthopedics The First Affiliated Hospital of Soochow University Suzhou Jiangsu China.
Medcomm
|June 8, 2026
Summary
Mitochondrial dysfunction is a key driver of aging and related diseases. This review synthesizes mechanisms, therapeutic strategies, and challenges in mitochondrial medicine for aging intervention.
Area of Science:
- Gerontology
- Mitochondrial Biology
- Cellular Aging
Background:
- Aging involves cellular organelle decline, with mitochondrial dysfunction as a primary hallmark.
- Senescent cells exhibit intrinsic mitochondrial dysfunction and impaired quality control (mitophagy, dynamics, biogenesis).
- A gap exists in synthesizing mechanistic insights of mitochondrial dysfunction with therapeutic challenges in aging.
Purpose of the Study:
- To systematically review pathways of mitochondrial dysfunction in aging.
- To analyze the contribution of mitochondrial dysregulation to aging-related diseases.
- To explore mitochondrial-targeted therapeutic strategies and clinical obstacles.
Main Methods:
- Systematic literature review and synthesis.
- Analysis of molecular pathways (e.g., mitochondrial DNA instability, cGAS-STING pathway).
- Evaluation of therapeutic interventions (metabolic, kinetic, disease-specific, novel technologies).
Main Results:
- Mitochondrial dysfunction, including DNA instability and inflammation, contributes to muscle, bone, neurodegenerative, cardiovascular, and metabolic diseases.
- Therapeutic strategies range from metabolic regulation to advanced approaches like mitochondrial transplantation and DNA base editing.
- Tissue-specific mitochondrial heterogeneity presents a significant challenge for clinical translation.
Conclusions:
- Understanding mitochondrial dysfunction mechanisms is crucial for developing effective aging interventions.
- Targeting mitochondria offers promising therapeutic avenues for age-related pathologies.
- Overcoming clinical translation barriers, such as heterogeneity, is essential for advancing mitochondrial medicine.
Related Concept Videos
01:37Mitochondria
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
01:46Electron Transport Chain: Complex I and II
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
01:45Mitochondrial Membranes
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
01:19Translocation of Proteins into the Mitochondria
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
01:28The Inner Mitochondrial Membrane
The inner mitochondrial membrane is the primary site of ATP synthesis. The inner membrane domain that forms a smooth layer adjacent to the outer membrane is called the inner boundary membrane. This domain contains membrane transporters that drive metabolites in and out of the mitochondria. In contrast, the inner membrane network that invaginates into the matrix space is called the cristae membrane. This domain accounts for principle mitochondrial function as it accommodates the protein...